Literature DB >> 16461895

Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.

Nuri Ozturk1, Esra Erdal, Mine Mumcuoglu, Kamil C Akcali, Ozden Yalcin, Serif Senturk, Ayca Arslan-Ergul, Bala Gur, Isik Yulug, Rengul Cetin-Atalay, Cengiz Yakicier, Tamer Yagci, Mesut Tez, Mehmet Ozturk.   

Abstract

Tumor cells have the capacity to proliferate indefinitely that is qualified as replicative immortality. This ability contrasts with the intrinsic control of the number of cell divisions in human somatic tissues by a mechanism called replicative senescence. Replicative immortality is acquired by inactivation of p53 and p16INK4a genes and reactivation of hTERT gene expression. It is unknown whether the cancer cell replicative immortality is reversible. Here, we show the spontaneous induction of replicative senescence in p53-and p16INK4a-deficient hepatocellular carcinoma cells. This phenomenon is characterized with hTERT repression, telomere shortening, senescence arrest, and tumor suppression. SIP1 gene (ZFHX1B) is partly responsible for replicative senescence, because short hairpin RNA-mediated SIP1 inactivation released hTERT repression and rescued clonal hepatocellular carcinoma cells from senescence arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461895      PMCID: PMC1413736          DOI: 10.1073/pnas.0510877103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites.

Authors:  J E Remacle; H Kraft; W Lerchner; G Wuytens; C Collart; K Verschueren; J C Smith; D Huylebroeck
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

2.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors:  B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 3.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 5.  Understanding transformation: progress and gaps.

Authors:  Jesse S Boehm; William C Hahn
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

6.  SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes.

Authors:  K Verschueren; J E Remacle; C Collart; H Kraft; B S Baker; P Tylzanowski; L Nelles; G Wuytens; M T Su; R Bodmer; J C Smith; D Huylebroeck
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

7.  p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

Authors:  M Volkmann; W J Hofmann; M Müller; U Räth; G Otto; H Zentgraf; P R Galle
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

Authors:  S Kaneko; P Hallenbeck; T Kotani; H Nakabayashi; G McGarrity; T Tamaoki; W F Anderson; Y L Chiang
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

10.  Myc activates telomerase.

Authors:  J Wang; L Y Xie; S Allan; D Beach; G J Hannon
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

View more
  23 in total

1.  Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Authors:  Ester Sánchez-Tilló; Laura Siles; Oriol de Barrios; Miriam Cuatrecasas; Eva C Vaquero; Antoni Castells; Antonio Postigo
Journal:  Am J Cancer Res       Date:  2011-08-20       Impact factor: 6.166

2.  Reactive oxygen species generation is essential for cisplatin-induced accelerated senescence in hepatocellular carcinoma.

Authors:  Kai Qu; Ting Lin; Zhixin Wang; Sinan Liu; Hulin Chang; Xinsen Xu; Fandi Meng; Lei Zhou; Jichao Wei; Minghui Tai; Yafeng Dong; Chang Liu
Journal:  Front Med       Date:  2014-04-22       Impact factor: 4.592

Review 3.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

4.  Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.

Authors:  Francesca Buontempo; Tulin Ersahin; Silvia Missiroli; Serif Senturk; Daniela Etro; Mehmet Ozturk; Silvano Capitani; Rengul Cetin-Atalay; Maria Luca Neri
Journal:  Invest New Drugs       Date:  2010-07-14       Impact factor: 3.850

5.  Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.

Authors:  Pelin Balcik-Ercin; Metin Cetin; Irem Yalim-Camci; Gorkem Odabas; Nurettin Tokay; A Emre Sayan; Tamer Yagci
Journal:  Cell Oncol (Dordr)       Date:  2018-03-07       Impact factor: 6.730

6.  HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.

Authors:  Tzu-Yue Shiu; Yu-Lueng Shih; An-Chieh Feng; Hsuan-Hwai Lin; Shih-Ming Huang; Tien-Yu Huang; Chung-Bao Hsieh; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  J Mol Med (Berl)       Date:  2017-03-03       Impact factor: 4.599

7.  The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity.

Authors:  Mine Mumcuoglu; Sevgi Bagislar; Haluk Yuzugullu; Hani Alotaibi; Serif Senturk; Pelin Telkoparan; Bala Gur-Dedeoglu; Burcu Cingoz; Betul Bozkurt; Uygar H Tazebay; Isik G Yulug; K Can Akcali; Mehmet Ozturk
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

8.  SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.

Authors:  A Emre Sayan; Thomas R Griffiths; Raj Pal; Gareth J Browne; Andrew Ruddick; Tamer Yagci; Richard Edwards; Nick J Mayer; Hasan Qazi; Sandeep Goyal; Serena Fernandez; Kees Straatman; George D D Jones; Karen J Bowman; Alexandra Colquhoun; J Kilian Mellon; Marina Kriajevska; Eugene Tulchinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 9.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

Review 10.  EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.

Authors:  Ester Sánchez-Tilló; Yongqing Liu; Oriol de Barrios; Laura Siles; Lucia Fanlo; Miriam Cuatrecasas; Douglas S Darling; Douglas C Dean; Antoni Castells; Antonio Postigo
Journal:  Cell Mol Life Sci       Date:  2012-09-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.